World Stroke Day October 29th
The key objectives are to raise awareness and highlight the imporatance of improved outcomes due to access to best-practice evidence-based treatments.
The key objectives are to raise awareness and highlight the imporatance of improved outcomes due to access to best-practice evidence-based treatments.
Now a missing value is better highlighted in the data form in the SITS Registry.
The ESO-Karolinska Stroke Update 2016 meeting offers a place for international stroke professionals to discuss implementation of new research into guidelines and clinical routine.
Mr Rizvi will be responsible for SITS user support, helpdesk and the data quality follow-up in the registries and studies.… Read More »Two new colleagues at SITS Coordinating office
As we informed in an earlier announcement, the SITS registry is now providing a new set of data variables available for… Read More »Data entry option for antidote of dabigatran now available in the SITS registry
Idarucizumab (Praxbind) is a fully humanized, monoclonal antibody which is a specific antidote to reverse the anticoagulant effect of dabigatran… Read More »Data entry option on antidote for dabigatran
Join us in Barcelona at the ESOC congress 10-12 May. You will find us in booth 36 & 37. Welcome!
Recommendations approved at the ESO-Karolinska Stroke Update consensus meeting in November 2014.
The SITS Report 2015 has just been released and can be downloaded as pdf! Happy New Year 2016 to all… Read More »SITS Report 2015